Literature DB >> 21830837

Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.

Roald Gerritsen1, Hans Faddegon, Fred Dijkers, Kees van Grootheest, Eugène van Puijenbroek.   

Abstract

BACKGROUND: Spontaneous reporting is a cornerstone of pharmacovigilance. Unfamiliarity with the reporting of suspected adverse drug reactions (ADRs) is a major factor leading to not reporting these events. Medical education may promote more effective reporting. Numerous changes have been implemented in medical education over the last decade, with a shift in training methods from those aimed predominantly at the transfer of knowledge towards those that are more practice based and skill oriented. It is conceivable that these changes have an impact on pharmacovigilance training in vocational training programmes. Therefore, this study compares the effectiveness of a skill-oriented, practice-based pharmacovigilance training method, with a traditional, lecture-based pharmacovigilance training method in the vocational training of general practitioners (GPs). The traditional, lecture-based method is common practice in the Netherlands.
OBJECTIVE: The purpose of this study was to establish whether the use of a practice-based, skill-oriented method in pharmacovigilance training during GP traineeship leads to an increase of reported ADRs after completion of this traineeship, compared with a lecture-based method. We also investigated whether the applied training method has an impact on the documentation level of the reports and on the number of unlabelled events reported. STUDY
DESIGN: A retrospective cohort study. The number of ADR reports submitted to the Netherlands Pharmacovigilance Centre Lareb (between January 2006 and October 2010) after completion of GP vocational training was compared between the two groups. Documentation level of the reports and the number of labelled/unlabelled events reported were also compared.
RESULTS: The practice-based cohort reported 32 times after completion of training (124 subjects, 6.8 reports per 1000 months of follow-up; total follow-up of 4704 months). The lecture-based cohort reported 12 times after training (135 subjects, 2.1 reports per 1000 months of follow-up; total follow-up of 5824 months) [odds ratio 2.9; 95% CI 1.4, 6.1]. Reports from GPs with practice-based training had a better documentation grade than those from GPs with lecture-based training, and more often concerned unlabelled events.
CONCLUSIONS: The practice-based method resulted in significantly more and better-documented reports and more often concerned unlabelled events than the lecture-based method. This effect persisted and did not appear to diminish over time.

Mesh:

Year:  2011        PMID: 21830837     DOI: 10.2165/11592800-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  16 in total

1.  Changing provider behavior: an overview of systematic reviews of interventions.

Authors:  J M Grimshaw; L Shirran; R Thomas; G Mowatt; C Fraser; L Bero; R Grilli; E Harvey; A Oxman; M A O'Brien
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

2.  Labelling and 'Dear Doctor' letters: are they noncommittal?

Authors:  A C Kees van Grootheest; I Ralph Edwards
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Evidence for the effectiveness of techniques To change physician behavior.

Authors:  W R Smith
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

Review 4.  Deliberate practice and the acquisition and maintenance of expert performance in medicine and related domains.

Authors:  K Anders Ericsson
Journal:  Acad Med       Date:  2004-10       Impact factor: 6.893

5.  An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Authors:  Adolfo Figueiras; Maria T Herdeiro; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

Review 6.  Lifelong learning at work.

Authors:  P W Teunissen; Tim Dornan
Journal:  BMJ       Date:  2008-03-22

Review 7.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

Review 9.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

10.  Attitudes, norms and controls influencing lifestyle risk factor management in general practice.

Authors:  Amanda J Ampt; Cheryl Amoroso; Mark F Harris; Suzanne H McKenzie; Vanessa K Rose; Jane R Taggart
Journal:  BMC Fam Pract       Date:  2009-08-26       Impact factor: 2.497

View more
  6 in total

1.  Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; María Piñeiro-Lamas; Adolfo Figueiras
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

2.  A global view of undergraduate education in pharmacovigilance.

Authors:  Jenny Hartman; Linda Härmark; Eugène van Puijenbroek
Journal:  Eur J Clin Pharmacol       Date:  2017-03-17       Impact factor: 2.953

3.  Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.

Authors:  Geneviève Durrieu; Julien Jacquot; Mathilde Mège; Emmanuelle Bondon-Guitton; Vanessa Rousseau; François Montastruc; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

Review 4.  Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance.

Authors:  Ram Kumar Sahu; Rajni Yadav; Pushpa Prasad; Amit Roy; Shashikant Chandrakar
Journal:  Springerplus       Date:  2014-11-26

5.  Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.

Authors:  Tim Schutte; Jelle Tichelaar; Michael O Reumerman; Rike van Eekeren; Leàn Rolfes; Eugène P van Puijenbroek; Milan C Richir; Michiel A van Agtmael
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

6.  What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.

Authors:  Rike van Eekeren; Leàn Rolfes; Andries S Koster; Lara Magro; Gurumurthy Parthasarathi; Hussain Al Ramimmy; Tim Schutte; Daisuke Tanaka; Eugène van Puijenbroek; Linda Härmark
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.